Low-Level Laser Therapy Promoted Aggressive Proliferation and Angiogenesis Through Decreasing of Transforming Growth Factor-β1 and Increasing of Akt/Hypoxia Inducible Factor-1α in Anaplastic Thyroid Cancer

Rhee, Yun-Hee; Moon, Jun Hyuk; Choi, Seung‐Hyuk; Ahn, Jin‐Chul

doi:10.1089/pho.2015.3968

Cited by 53 publications

(25 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A total of 15 in vivo studies investigating the safety of PBMT in different animal cancer models were identified (Table 2). 62,63,[71][72][73][74][75][76][77][78][79][80][81][82][83] In a study with a chemically induced OSCC hamster cheek pouch model, PBM (660 nm, 30 mW, 424 mW/cm 2 , 56.4 J/cm 2 , and 133 s, 4 J) led to tumor progression. 76 In contrast, a study with a mouse model of multiple UV-induced skin tumors, full-body PBM (670 nm, twice a day, 5 J/cm 2 for 37 days) did not enhance tumor growth in comparison with sham-treated animals.…”

Section: In Vivo Studiesmentioning

confidence: 99%

Safety and efficacy of photobiomodulation therapy in oncology: A systematic review

et al. 2020

View full text Add to dashboard Cite

show abstract

Section: In Vivo Studiesmentioning

confidence: 99%

Safety and efficacy of photobiomodulation therapy in oncology: A systematic review

et al. 2020

View full text Add to dashboard Cite

show abstract

“…was also frequently seen. [35][36][37][38][39] Furthermore, TGF-GFhas been found to be associated with cisplatin-resistant neoplasms. [40][41][42] As a transforming growth factor, TGF-a has not been thoroughly studied in thyroid carcinoma especially ATC with cisplatin-resistance, remaining a gap field of thyroid carcinoma.…”

Section: Introductionmentioning

confidence: 99%

Effects of miR-144 on the sensitivity of human anaplastic thyroid carcinoma cells to cisplatin by autophagy regulation

Liu

Feng

Zhang

et al. 2018

Cancer Biology & Therapy

View full text Add to dashboard Cite

show abstract

“…Although LLLT has been reported to have a suppressive effect on cancer cells 94 – 97 , studies using rodent models suggest that it might modify cancer cell behavior and actually lead to stimulation of dysplastic cells 98 – 101 . For example, Rhee et al 102 reported that LLLT increased tumor size in rodents when thyroid cancer cells were directly exposed to photodynamic (laser) therapy. Clearly, additional studies with both LLLT and HILT are needed in patients with cancer.…”

Section: Laser Therapymentioning

confidence: 99%

Use of electroanalgesia and laser therapies as alternatives to opioids for acute and chronic pain management

White

Elvir-Lazo

Galeas³

et al. 2017

F1000Res

View full text Add to dashboard Cite

The use of opioid analgesics for postoperative pain management has contributed to the global opioid epidemic. It was recently reported that prescription opioid analgesic use often continued after major joint replacement surgery even though patients were no longer experiencing joint pain. The use of epidural local analgesia for perioperative pain management was not found to be protective against persistent opioid use in a large cohort of opioid-naïve patients undergoing abdominal surgery. In a retrospective study involving over 390,000 outpatients more than 66 years of age who underwent minor ambulatory surgery procedures, patients receiving a prescription opioid analgesic within 7 days of discharge were 44% more likely to continue using opioids 1 year after surgery. In a review of 11 million patients undergoing elective surgery from 2002 to 2011, both opioid overdoses and opioid dependence were found to be increasing over time. Opioid-dependent surgical patients were more likely to experience postoperative pulmonary complications, require longer hospital stays, and increase costs to the health-care system. The Centers for Disease Control and Prevention emphasized the importance of finding alternatives to opioid medication for treating pain. In the new clinical practice guidelines for back pain, the authors endorsed the use of non-pharmacologic therapies. However, one of the more widely used non-pharmacologic treatments for chronic pain (namely radiofrequency ablation therapy) was recently reported to have no clinical benefit. Therefore, this clinical commentary will review evidence in the peer-reviewed literature supporting the use of electroanalgesia and laser therapies for treating acute pain, cervical (neck) pain, low back pain, persistent post-surgical pain after spine surgery (“failed back syndrome”), major joint replacements, and abdominal surgery as well as other common chronic pain syndromes (for example, myofascial pain, peripheral neuropathic pain, fibromyalgia, degenerative joint disease/osteoarthritis, and migraine headaches).

show abstract

Low-Level Laser Therapy Promoted Aggressive Proliferation and Angiogenesis Through Decreasing of Transforming Growth Factor-β1 and Increasing of Akt/Hypoxia Inducible Factor-1α in Anaplastic Thyroid Cancer

Cited by 53 publications

References 17 publications

Safety and efficacy of photobiomodulation therapy in oncology: A systematic review

Safety and efficacy of photobiomodulation therapy in oncology: A systematic review

Effects of miR-144 on the sensitivity of human anaplastic thyroid carcinoma cells to cisplatin by autophagy regulation

Use of electroanalgesia and laser therapies as alternatives to opioids for acute and chronic pain management

Contact Info

Product

Resources

About